2-oxoglutarate + NADPH + H+ => (R)-2-hydroxyglutarate + NADP+ [mutant IDH1]

Stable Identifier
Reaction [transition]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Mutant forms of IDH1 in which the arginine residue at position 132 has been replaced by histidine, cystine, leucine, or serine catalyze the reaction of 2-oxoglutarate and NADPH + H+ to form (R)-2-hydroxyglutarate and NADP+. Like normal IDH1, the mutant enzyme forms a dimer located in the cytosol (Dang et al. 2009).

Such mutations occur frequently as a somatic event in human glioblastomas (Parsons et al. 2008). Cells expressing the mutant protein accumulate elevated levels of 2-hydroxyglutarate, probably in the cytosol as IDH1 is a cytosolic enzyme. The fate of the 2-hydroxyglutarate is unclear, but the high frequency with which the mutation is found in surveys of primary tumors is consistent with the possibility that it is advantageous to the tumor cells (Dang et al. 2009).

Literature References
PubMed ID Title Journal Year
19935646 Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Keenan, MC, White, DW, Su, SM, Liau, LM, Yen, KE, Bittinger, MA, Gross, S, Fantin, VR, Dang, L, Thompson, CB, Jin, S, Cantley, LC, Rabinowitz, JD, Ward, PS, Bennett, BD, Jang, HG, Marks, KM, Prins, RM, Vander Heiden, MG, Driggers, EM

Nature 2009
Catalyst Activity

(R)-2-hydroxyglutarate dehydrogenase activity of IDH1 R132mutant dimers [cytosol]

Name Identifier Synonyms
glioblastoma multiforme DOID:3068 GBM, adult glioblastoma multiforme, grade IV adult Astrocytic tumor, primary glioblastoma multiforme, spongioblastoma multiforme
Cross References
Cite Us!